Elisa Micarelli

5PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesInnate immunityBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 11, 2026
Mutations Targeted by Nous-209 Immunotherapy Occur Early in Lynch Syndrome Carriers' Precancer Lesions with Microsatellite Instability.

|Nov 13, 2025
NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome.

Lorenzo De Marco, Elisa Micarelli, Joni Panula

|Mar 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.

Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno

|Aug 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejection.

Anna Morena D'Alise, Nadia Brasu, Carlo De Intinis

|Jun 27, 2019
Fibro-adipogenic progenitors of dystrophic mice are insensitive to NOTCH regulation of adipogenesis.

Milica Marinkovic, Claudia Fuoco, Francesca Sacco

Pageof 1

Frequent Collaborators

4 joint publications

Anna Morena D'Alise

4 joint publications

Elisa Scarselli

2 joint publications

Lorenzo De Marco

2 joint publications

Guido Leoni